Healthpeak Properties (NYSE:DOC – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided EPS guidance of $1.79-1.81 for the period, compared to the consensus estimate of $1.79. Healthpeak Properties also updated its FY 2024 guidance to 1.560-1.580 EPS.
Healthpeak Properties Price Performance
DOC stock opened at $22.29 on Friday. The company has a market capitalization of $15.59 billion, a P/E ratio of 47.43, a PEG ratio of 3.30 and a beta of 1.14. The company has a fifty day moving average price of $22.26 and a 200-day moving average price of $20.67. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.70 and a current ratio of 0.70. Healthpeak Properties has a 52-week low of $15.24 and a 52-week high of $23.26.
Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its quarterly earnings data on Thursday, July 25th. The real estate investment trust reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.23). The company had revenue of $695.50 million during the quarter, compared to analyst estimates of $665.11 million. Healthpeak Properties had a return on equity of 3.51% and a net margin of 11.93%. Healthpeak Properties’s revenue was up 27.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.45 earnings per share. As a group, equities analysts expect that Healthpeak Properties will post 1.79 EPS for the current year.
Healthpeak Properties Dividend Announcement
Analyst Upgrades and Downgrades
Several research analysts have issued reports on the company. Wells Fargo & Company reiterated an “equal weight” rating and issued a $23.00 price target (up previously from $22.00) on shares of Healthpeak Properties in a report on Tuesday, October 1st. Evercore ISI increased their target price on Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a report on Monday, September 16th. Wedbush lifted their price target on shares of Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a research report on Monday, July 29th. StockNews.com downgraded shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Saturday, October 19th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and raised their price objective for the company from $20.00 to $28.00 in a research note on Monday, October 21st. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $22.62.
View Our Latest Research Report on Healthpeak Properties
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles
- Five stocks we like better than Healthpeak Properties
- What is a Dividend King?
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Most Volatile Stocks, What Investors Need to Know
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Best Aerospace Stocks Investing
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.